ANTHONY DENINA: Open Payments
NPI 1427551936 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$758 in 6 payments from 6 companies in 2025. Trend: 2023 $295 · 2024 $0 · 2025 $758
Food & beverage: $758
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 1 | $146 |
| ABBVIE INC. | 1 | $125 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $124 |
| AstraZeneca Pharmaceuticals LP | 1 | $122 |
| Gilead Sciences, Inc. | 1 | $122 |
| Novo Nordisk Inc | 1 | $119 |
Products named: IQIRVO, CREON, XIFAXAN, AIRSUPRA, Vemlidy, Wegovy.
Industry payments across NV — which companies pay providers there.
